KOR

e-Article

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial
Document Type
Article
Author
Powles, T.Csőszi, T.Özgüroğlu, M.Matsubara, N.Géczi, L.Cheng, S.Y.-S.Fradet, Y.Oudard, S.Vulsteke, C.Morales Barrera, R.Fléchon, A.Gunduz, S.Loriot, Y.Rodriguez-Vida, A.Mamtani, R.Yu, E.Y.Nam, K.Imai, K.Homet Moreno, B.Alva, A.Cascallar, D.V.Varela, M.Lazzaro, M.F.Kaen, D.L.Gatica, G.Flores, D.H.Falco, A.Molina, M.Van Aelst, F.Sautois, B.Machiels, J.-P.Schallier, D.Brust, L.Rapatoni, L.Azevedo, S.J.Marinho, G.Soares, J.P.H.Dzik, C.Almeida Silva, J.Fay, A.P.Gingerich, J.Ferrario, C.Potvin, K.Vanhuyse, M.Abdelsalam, M.Cheng, S.Caglevic, C.Reyes, F.Leal, J.L.Francisco, F.Ibanez, C.Joly, F.Laguerre, B.Ladoire, S.Flechon, A.Topart, D.Huillard, O.Oudard, S.Gross-Goupil, M.Culine, S.Gravis, G.Reichardt, P.Retz, M.Herden, J.Pfister, D.Ohlman, C.Stoeckle, M.Wirth, M.Lorch, A.Niegisch, G.Goebell, P.J.Boegemann, M.Merseburger, A.Gakis, G.Bedke, J.Neisius, A.Thomas, C.Hoefner, T.Telekes, A.Kosa, J.E.Revesz, J.Bodoky, G.Csoszi, T.Csejtei, A.Geczi, L.Ruzsa, A.Kolonics, Z.Erfan, J.McDermott, R.Bambury, R.Sella, A.Frank, S.J.Kejzman, D.Goldman, O.Rosenbaum, E.Peer, A.Berger, R.Rouvinov, K.Sarid, D.Fukasawa, S.Arai, G.Yamaguchi, A.Yokomizo, A.Takayama, T.Kinoshita, H.Kikuchi, E.Mizuno, R.Fujii, Y.Sassa, N.Matsukawa, Y.Fujimoto, K.Tanikawa, T.Tomita, Y.Nishimura, K.Tsujihata, M.Oyama, M.Masumori, N.Kanayama, H.Takano, T.Miura, Y.Miyazaki, J.Joraku, A.Kimura, T.Yamamoto, Y.Kobayashi, K.De Wit, R.Aarts, M.Gerritsen, W.Los, M.Beerepoot, L.Izmailov, A.Gorelov, S.I.Alekseev, B.Y.Semenov, A.Kostorov, V.A.Alekseev, S.M.Zyryanov, A.Oschepkov, V.N.Shidin, V.A.Vladimirov, V.I.Gafanov, R.A.Karlov, P.A.Anderson, D.B.Shepherd, L.Cohen, G.L.Rapoport, B.L.Ruff, P.Lee, N.Bae, W.K.Lee, H.J.Herranz, U.A.Grande, E.Alonso Gordoa, T.Guma Padro, J.Gauna, D.C.Arranz, J.A.Munoz Langa, J.Sarrio, R.G.Montesa Pino, A.Juan Fita, M.J.Su, Y.-L.Lin, Y.-C.Su, W.-P.Shen, Y.-C.Chang, Y.-H.Huang, Y.-H.Sriuranpong, V.Chansriwong, P.Srimuninnimit, V.Danchaivijitr, P.Abali, H.Yavuz, S.Ozyilkan, O.Sendur, M.A.N.Ekenel, M.Ozguroglu, M.Arslan, C.Ozdogan, M.Birtle, A.Huddart, R.de Santis, M.Zarkar, A.Evans, L.Hussain, S.DiSimone, C.Muina, A.F.Schlegel, P.Jhangiani, H.S.Harrison, M.Slater, D.E.Wright, D.Percent, I.J.Lin, J.Hwang, C.Gupta, S.Bajaj, M.Galamaga, R.Eklund, J.Wallace, J.Shtivelband, M.Suh, J.J.-G.Burhani, N.Eadens, M.Gunturu, K.Burgess, E.Wong, J.Chaudhry, A.Van Veldhuizen, P.Graff, S.Thomas, C.A.Schnadig, I.D.Carneiro, B.Hussain, M.Morgans, A.Fitzharris, J.T.Oliff, I.A.Vuky, J.Hauke, R.Baron, A.Joshi, M.Bolemon, B.H.Jiang, P.Mega, A.E.Markus, M.Pfanzelter, N.Lawler, W.E.Cobb, P.W.Courtright, J.G.Jain, S.Doshi, G.Gunuganti, V.K.Sartor, O.A.Cole, S.W.Babiker, H.Uchio, E.M.Drakaki, A.Mannuel, H.D.Guancial, E.Fung, C.Charles, A.Amato, R.J.Arriaga, Y.Bowman, I.Ades, S.Dreicer, R.Yu, E.Quinn, D.I.Fleming, M.
Source
In: The Lancet Oncology. (The Lancet Oncology, July 2021, 22(7):931-945)
Subject
Language
English
ISSN
14745488
14702045